March
Astellas makes offer to buy OSI
Global pharma company, Astellas, is to commence a tender offer to acquire all outstanding shares of common stock of OSI Pharmaceuticals
01 Mar 2010
Increase in UK R&D spend
The latest R&D Scoreboard reveals biotech and pharma firms dominate the list of UK companies which invested over £26bn in development in 2008
01 Mar 2010
Archimedes announce fundraising of £65m
Archimedes Pharma has announced £65m in new funding following a major investment from Novo Growth Equity, the growth equity fund of Novo A/S
02 Mar 2010
Update on AZ-Merck deal
AZ will buy rights to several of Merck's marketed and pipeline products at a cost of $674m, as announced in an update regarding their joint venture
02 Mar 2010
Baxter to acquire ApaTech equity
Baxter will acquire all of ApaTech's outstanding equity for total consideration of up to $330m, in an agreement announced this week
02 Mar 2010
AstraZeneca announces 1,200 UK job cuts
AstraZeneca has announced plans to close its Leicestershire research facility with the loss of 1,200 jobs
03 Mar 2010
Bristol-Myers Squibb names new CEO
Lamberto Andreotti will take over from James Cornelius as CEO at Bristol-Myers Squibb, with Cornelius staying on as chairman
03 Mar 2010
BHBIA calls for BOBI Award votes
Voting for the BOBI Business Intelligence Excellence Awards is now open and the BHBIA is encouraging members to place their votes
03 Mar 2010
Kantar Health appoints Ceri Thomas
Global healthcare-focused consultancy, Kantar Health has appointed Ceri Thomas as head of global marketing
03 Mar 2010
EURORDIS surveys patient organisations
Survey finds patient organisations across Europe are keen to support research into rare diseases, through providing both insight and funding
03 Mar 2010